News & Analysis as of

Clinical Trials Court of Justice of the European Union (CJEU)

Hogan Lovells

CJEU: Trademark use in clinical trials, no bar to non-use revocation

Hogan Lovells on

This month, the Court of Justice of the European Union (CJEU) addressed a case of particular interest for pharmaceutical companies that are in the process of developing a new product. Regulatory and commercial considerations...more

Hogan Lovells

The EU Court of Justice dismisses EMA's appeals in interim measures and suspends the release of clinical study report to third...

Hogan Lovells on

On March, 1st 2017, by Order of its Vice-President, the Court of Justice of the EU (“CJEU”) upheld the suspension of the release to third parties of a clinical study report concerning the medicinal product Translarna granted...more

2 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide